Pandemic ‘Roadmap’ Will Show How To Develop New Vaccines in 100 Days
AMR, Clinical Trials & Digital Health Also Discussed At Oxford G7 Event
Executive Summary
The pharmaceutical industry is a key player in a new partnership that aims to bring the public and private sectors together to address future complex health threats.
You may also be interested in...
SCARDA: Japan’s New Vaccine R&D Center With $1.6bn Budget – But Where's The Goal?
Japan has launched a new center to support vaccine and drug projects as a part of a larger scheme to tackle infectious disease. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects.
Coronavirus Notebook: G7 Agree On ‘Clinical Trial Charter’, Regulators Focus On Real World Data
The European Medicines Agency has issued advice on managing thrombosis with thrombocytopenia syndrome (TTS) in people vaccinated with adenovirus vaccines, and Brazil has OKd the import of Sputnik V and Covaxin, albeit with numerous strings attached.
UK Gathers Global Leaders For Pandemic Preparedness Project
New government funding to boost vaccine manufacturing and research into variant vaccines is being made available as part of the UK’s ambitious plans for a partnership to accelerate the availability of vaccines and other products for future pandemics.